Canakinumab Biosimilar (IL-1b Reference Antibody)
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.
Product Specifications
Target
Canakinumab Biosimilar (Anti-IL-1b Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RDR-TSC22-Hu-01 96 Tests
Human Transforming Growth Factor Beta Stimulated Protein Clone 22 (TSC22) ELISA Kit
Sign In for Pricing
View Details RDR-TSC22-Hu-02 48 Tests
Human Transforming Growth Factor Beta Stimulated Protein Clone 22 (TSC22) ELISA Kit
Sign In for Pricing
View Details 
